Back to search results

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Israel
RecruitingPHASE1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Breast Cancer · Small Cell Lung Cancer · Ovarian Cancer · Gastric Cancer · Hormone-receptor-positive Breast Cancer · Hormone Receptor Positive HER-2 Negative Breast Cancer · Advanced Solid Tumor · Endometrial Cancer · Prostate Cancer · TNBC - Triple-Negative Breast Cancer · GastroEsophageal Cancer · Bladder Cancer

Locations
  • Hoag Memorial Presbyterian, Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute, Lake Mary, Florida, United States
  • Washington University School of Medicine, St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick, New Jersey, United States
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States
  • Mary Crowley Cancer Research, Dallas, Texas, United States
  • Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, Australia
  • Saint Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia
  • Nepean Hospital, Kingswood, New South Wales, Australia
  • Genesiscare North Shore, St Leonards, New South Wales, Australia
  • Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
  • Cancer Research South Australia, Adelaide, South Australia, Australia
  • Monash Health, Clayton, Victoria, Australia
  • Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital, Beijing, Beijing Municipality, China
  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
  • Hunan Cancer Hospital, Changsha, Hunan, China
  • Shengjing Hospital Affiliated of China Medical University, Shenyang, Liaoning, China
  • The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
  • Rambam Health Care Center, Haifa, Israel
  • Shaare Zedek Medical Center, Jerusalem, Israel
  • The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Moldova
  • Auckland City Hospital, Auckland, New Zealand
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)